Compagnie Lombard Odier SCmA - GT BIOPHARMA INC ownership

GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 51 filers reported holding GT BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Compagnie Lombard Odier SCmA ownership history of GT BIOPHARMA INC
ValueSharesWeighting
Q3 2023$12,055
-22.7%
50,0000.0%0.00%
Q2 2023$15,600
-43.3%
50,0000.0%0.00%
-100.0%
Q1 2023$27,500
-38.9%
50,0000.0%0.00%0.0%
Q4 2022$45,000
-48.9%
50,0000.0%0.00%
-66.7%
Q3 2022$88,000
-2.2%
50,000
+66.7%
0.00%
+50.0%
Q2 2022$90,000
+4.7%
30,0000.0%0.00%0.0%
Q1 2022$86,000
-6.5%
30,0000.0%0.00%0.0%
Q4 2021$92,000
-8.9%
30,000
+100.0%
0.00%0.0%
Q3 2021$101,000
-56.7%
15,0000.0%0.00%
-60.0%
Q2 2021$233,00015,0000.01%
Other shareholders
GT BIOPHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Baskin Financial Services Inc. 151,354$360.00%
Moss Adams Wealth Advisors LLC 20,000$4,8220.00%
UBS Group AG 8,750$2,1090.00%
Compagnie Lombard Odier SCmA 50,000$12,0550.00%
OSAIC HOLDINGS, INC. 1,270$3050.00%
FMR LLC 150$360.00%
BANK OF AMERICA CORP /DE/ 508$1220.00%
WELLS FARGO & COMPANY/MN 300,697$72,4980.00%
NORTHERN TRUST CORP 32,347$7,7990.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of GT BIOPHARMA INC shareholders